P4‐388: XANAMEMTM: A Novel 11B‐HSD1 Inhibitor with Potential to Provide Durable Symptomatic and Disease Modifying Benefits in Alzheimer'S Disease. (1st July 2016) - Ritchie, Craig W.; Webster, Scott; Cummings, Jeffrey L.; Masters, Colin L.; Ruffles, Vincent; Seckl, Jonathan; Walker, Brian R.